Elite Pharmaceuticals Inc (ELTP)

[sharkey1]

# 2,
It continues, you have to read in reverse to get it to make sense.

"Herein lies the problem: We don’t have control of the precious drugs that ultimately are integral to patient care in the U.S.," Glatter said.

McGowan agreed the issue of sourcing materials can be playing into this, but said there are multiple areas in the supply chain that can be impacted.

In the case of the Wegovy shortage, the contract manufacturer in charge of filling the syringes, had to halt production due to a manufacturing issue, which disrupted the entire supply chain. That, coupled with the initial overwhelming demand, led to a nationwide shortage, according to McGowan.